TGF-beta(1) modulates NOS expression and phosphorylation of Akt/PKB in rat myocytes exposed to hypoxia-reoxygenation

Area of Science:

• Cardiovascular Biology
• Cellular Physiology
• Molecular Medicine

Background:

• Myocardial hypoxia-reoxygenation (H-R) injury involves altered nitric oxide synthase (NOS) and protein kinase B (PKB) signaling.
• Transforming growth factor-beta(1) (TGF-β(1)) has shown potential in mitigating H-R-induced myocardial damage.

Purpose of the Study:

• To investigate the effects of TGF-β(1) on NOS and PKB expression and activity during H-R in cardiac myocytes.
• To determine if TGF-β(1) can protect against H-R-induced myocyte injury.

Main Methods:

• Primary rat cardiac myocytes were subjected to hypoxia-reoxygenation (H-R) or normoxic conditions.
• Cells were treated with TGF-β(1) (1 ng/ml) prior to H-R exposure.
• Measurements included lactate dehydrogenase (LDH) release, iNOS activity, iNOS and eNOS expression, and PKB phosphorylation.

Main Results:

• H-R alone caused significant myocyte injury, increased iNOS activity and expression, decreased eNOS expression, and enhanced PKB phosphorylation.
• TGF-β(1) treatment significantly reduced LDH release, indicating protection against H-R injury.
• TGF-β(1) attenuated the H-R-induced alterations in iNOS and eNOS expression and PKB phosphorylation.

Conclusions:

• TGF-β(1) confers protection against myocardial hypoxia-reoxygenation injury.
• TGF-β(1) modulates the expression of iNOS and eNOS and affects PKB phosphorylation in response to H-R.
• These findings highlight TGF-β(1) as a potential therapeutic target for H-R-related cardiac conditions.